September 21, 2018
The Alliance submitted a letter to United Healthcare, requesting that it delay implementation of “Commercial Medical Policy 2018T0592A, Skin and Soft Tissue Substitutes. ” The policy, which is scheduled to become effective October 1, 2018, will “cause significant disruption in the care of your members in outpatient, hospital, rehabilitation, skilled nursing and other settings who are currently receiving skin and soft tissue substitutes for the management of their chronic wounds,” the Alliance wrote.  “We request a meeting with you to discuss our concerns, address issues regarding improvement in health outcomes with these therapies, and to offer recommendations that will serve to improve the clinical outcomes for your member patients at lower cost of care.”

Read Alliance Comment
logo
Email: marcia@woundcarestakeholders.org
Phone: 301.530.7846
Fax: 301.530.7946
5225 Pooks Hill Road
Suite 627 South
Bethesda, Maryland 20814
Follow us on:
linkedin